Illumina, Inc Patent Portfolio Statistics

Illumina, Inc.

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Illumina, Inc. look like?

Total Applications: 1,197
Granted Patents: 641
Grant Index 76.31 %
Abandoned/Rejected Applications: 199 (23.69%)
In-Process Applications: 350
Average Grant Time: 2.86 Years
Average Office Actions: 1.82

Which Technology Area Illumina, Inc. is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1637 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 201
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 158
Opap Parked GAU 157
1639 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 89
1631 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 62

How many patents are Illumina, Inc. filing every year?

Year Total Applications
2022 0*
2021 113*
2020 123
2019 148
2018 80

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Illumina, Inc. in USPTO?

Publication number:
Application number: 17/599,994

Abstract:
None

Publication date:
Applicant: Illumina, Inc.
Inventors: Antoine Francais


Publication number: US20220003728A1
Application number: 17/479,342

Abstract:
An apparatus includes a flow cell body, a plurality of electrodes, an imaging assembly, and one or more barrier features. The flow cell body defines one or more flow channels and a plurality of wells defined as recesses in the floor of each flow channel. Each well is fluidically coupled with the corresponding flow channel. The flow cell body further defines interstitial surfaces between adjacent wells. Each well defines a corresponding depth. Each electrode is positioned in a corresponding well of the plurality of wells. The electrodes are to effect writing of polynucleotides in the wells. The imaging assembly is to capture images of polynucleotides written in the wells. The one or more barrier features are positioned in the wells, between the wells, or above the wells. The one or more barrier features contain reactions in each well, reduce diffusion between the wells, or reduce optical cross-talk between the wells.

Publication date: 2022-01-06
Applicant: Illumina, Inc.
Inventors: Aathavan Karunakaran


Publication number: US20220002791A1
Application number: 17/479,718

Abstract:
A method for spatially tagging nucleic acids of a biological specimen, including steps of (a) providing a solid support comprising different nucleic acid probes that are randomly located on the solid support, wherein the different nucleic acid probes each includes a barcode sequence that differs from the barcode sequence of other randomly located probes on the solid support; (b) performing a nucleic acid detection reaction on the solid support to locate the barcode sequences on the solid support; (c) contacting a biological specimen with the solid support that has the randomly located probes; (d) hybridizing the randomly located probes to target nucleic acids from portions of the biological specimen; and (e) modifying the randomly located probes that are hybridized to the target nucleic acids, thereby producing modified probes that include the barcode sequences and a target specific modification, thereby spatially tagging the nucleic acids of the biological specimen.

Publication date: 2022-01-06
Applicant: Illumina, Inc.
Inventors: Joakim Lundeberg


How are Illumina, Inc.’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/599,994 Kits And Flow Cells
17/479,342 Flow Cell With One Or More Barrier Features Non Final Action Mailed 2886 Akanbi, Isiaka O
17/479,718 Spatially Distinguished, Multiplex Nucleic Acid Analysis Of Biological Specimens Non Final Action Mailed 1637 Thomas, David C
17/470,228 Obtaining Information From A Biological Sample In A Flow Cell Docketed New Case – Ready for Examination OPAP Central, Docket
17/464,417 Elongated Modular Heatsink With Coupled Light Source Docketed New Case – Ready for Examination OPAP Central, Docket